Related Experiment Video
Updated: May 15, 2025

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
Cholinesterase and Inflammation: Exploring Its Role and Associations with Inflammatory Markers in Patients with Lower
Maximilian Mitteregger1,2, Sabine Steiner1, Andrea Willfort-Ehringer1
1Department of Internal Medicine II, Division of Angiology, Medical University of Vienna, 1090 Vienna, Austria.
Insights
Serum cholinesterase (ChE) levels correlate with inflammation in lower extremity artery disease (LEAD). Lower ChE indicates higher inflammation, especially in critical ischemia, suggesting ChE as a potential biomarker for LEAD severity.
Area of Science:
- Vascular Medicine
- Inflammation Research
- Biomarker Discovery
Background:
- Inflammation is a key factor in atherosclerotic diseases like lower extremity artery disease (LEAD).
- Serum cholinesterase (ChE) influences cardiovascular health and modulates inflammatory responses.
Purpose of the Study:
- To examine the association between serum ChE levels and inflammatory markers in patients with hemodynamically significant iliac artery stenosis.
- To assess the role of ChE in the inflammatory processes underlying LEAD.
Main Methods:
- Retrospective analysis of 150 patients with iliac artery stenosis (δPSV ≥ 1.4 m/s).
- Investigated ChE relationship with neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), hemoglobin-to-platelet ratio (HPR), and other parameters.
Main Results:
- Significant difference in ChE levels between stable claudication and critical ischemia (7.76 mg/dL vs. 6.77 mg/dL, p = 0.004).
- Inverse correlation between ChE and NLR (r = -0.303, p < 0.001) and PLR (r = -0.162, p = 0.049).
- Positive correlation between ChE and body mass index (BMI) (r = 0.298, p < 0.001).
Conclusions:
- Findings suggest active inflammation in LEAD, particularly in critical ischemia.
- Serum ChE may serve as a potential biomarker for inflammation in LEAD, differentiating disease severity.
- Further research is warranted to explore ChE's role in cholinergic regulation of inflammation in LEAD.
Abstract:
Background: Inflammation is a major driver of atherosclerotic diseases including lower extremity artery disease (LEAD). Serum cholinesterase (ChE) has been shown to impact cardiovascular health and regulate inflammatory processes. Objectives: The aim of this study was to investigate the relationship between serum ChE levels and inflammatory markers in patients with hemodynamically relevant iliac artery stenosis, assessing its potential role in the inflammatory processes of lower extremity artery disease (LEAD). Methods: In the following retrospective data analysis, we investigated 150 patients with hemodynamically relevant iliac artery stenosis as documented by a delta peak systolic velocity (δPSV) ≥ 1.4 m/s and investigated the possible influence of ChE on established inflammatory markers, such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and hemoglobin-to-platelet ratio (HPR), along with other routine laboratory or vascular parameters. Results: ChE levels differed significantly between patients with stable claudication (Fontaine stage II) and critical ischemia (Fontaine stages III and IV): 7.76 mg/dL (6.55-8.7 mg/dL) vs. 6.77 mg/dL (5.85-7.48 mg/dL), p = 0.004. Using the spearman correlation coefficient, testing of NLR and ChE revealed a highly significant inverse correlation, with a coefficient of -0.303 (p < 0.001). Additionally, a weak inverse correlation was observed between PLR and ChE, with a coefficient of -0.162 (p = 0.049). Patients with an elevated body mass index (BMI) showed increased levels of serum ChE, with a spearman correlation coefficient of 0.298 (p < 0.001). Conclusions: The observed correlations in this study depict active inflammation in LEAD with an emphasis on patients with critical ischemia. Serum ChE could serve as a potential biomarker for inflammation in patients with LEAD, particularly in distinguishing between stable claudication and critical ischemia. Future research is needed to explore the role of ChE as a complementary biomarker, offering insights into the cholinergic regulation of inflammation in LEAD.
Related Concept Videos
Cholinesterases: Distribution and Function
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Inflammation
Cholesterol: Significance and Regulation
Considering cholesterol and...

